Lifeward (LFWD) Cash from Investing Activities (2015 - 2026)
Lifeward (LFWD) reported Cash from Investing Activities of $6.5 million for Q1 2026, up 130100.0% on a YoY basis from N/an in Q1 2025, and up 59190.91% sequentially from -$11000.0 in Q4 2025.
Lifeward (LFWD) Cash from Investing Activities (2015 - 2026) Analysis & Trends
Lifeward (LFWD) has 11 years of Cash from Investing Activities data on file, last reported at $6.5 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 130100.0% year-over-year to $6.5 million; the trailing twelve-month figure through Mar 2026 stood at $6.5 million (up 129880.0% YoY), and the FY2025 full-year result was -$16000.0, changed N/A from the prior year.
- Cash from Investing Activities grew to $6.5 million in Q1 2026, from -$11000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $6.5 million in Q1 2026 to a low of -$18.1 million in Q3 2023.
- A 4-year average of -$1.5 million and a median of -$9000.0 in 2022 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities plunged 258042.86% in 2023 and soared 130100.0% in 2026, its largest moves.
- Tracing LFWD's Cash from Investing Activities over 4 years: stood at -$7000.0 in 2022, then slumped by 1028.57% to -$79000.0 in 2023, then surged by 86.08% to -$11000.0 in 2025, then soared by 59190.91% to $6.5 million in 2026.
- Business Quant data shows LFWD's Cash from Investing Activities at $6.5 million in Q1 2026, -$11000.0 in Q4 2025, and -$5000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Lifeward | 11.46 Mn | 37,305.54 | 1.34 Mn | 6.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.50 Mn |
| Mar 31, 2026 | 6.50 Mn |
| Dec 31, 2025 | -11,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2023 | -79,000.00 |
| Dec 31, 2023 | -79,000.00 |
| Sep 30, 2023 | -18.07 Mn |
| Sep 30, 2023 | -18.07 Mn |
| Sep 30, 2022 | -7,000.00 |
| Sep 30, 2022 | -7,000.00 |
| Jun 30, 2022 | -15,000.00 |
| Jun 30, 2022 | -15,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | -19,000.00 |
| Dec 31, 2021 | -19,000.00 |
| Sep 30, 2021 | -17,000.00 |
| Sep 30, 2021 | -17,000.00 |